Literature DB >> 20006400

Entecavir in decompensated HBV cirrhosis: the future is looking brighter.

Robert J Fontana.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 20006400     DOI： 10.1016/j.jhep.2009.10.025

Source DB:  PubMed          Journal:  J Hepatol        ISSN： 0168-8278            Impact factor:   25.083


× No keyword cloud information.
  4 in total

Review 1.  Entecavir: a review of its use in the treatment of chronic hepatitis B in patients with decompensated liver disease.

Authors:  Gillian M Keating
Journal:  Drugs       Date:  2011-12-24       Impact factor: 9.546

2.  Lactic Acidosis during Entecavir Antiviral Treatment in a Patient with Hepatitis B Virus-related Decompensated Cirrhosis.

Authors:  H Mao; T Kang
Journal:  West Indian Med J       Date:  2015-01-27       Impact factor: 0.171

Review 3.  Prevention of hepatitis B virus-associated liver diseases by antiviral therapy.

Authors:  Akinobu Tawada; Tatsuo Kanda; Fumio Imazeki; Osamu Yokosuka
Journal:  Hepatol Int       Date:  2016-03-29       Impact factor: 6.047

Review 4.  Management of chronic hepatitis B before and after liver transplantation.

Authors:  B Wang; K Agarwal; D Joshi
Journal:  Frontline Gastroenterol       Date:  2017-02-14
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.